Description
Tirzepatide is a dual GIP/GLP-1 receptor-agonist peptide supplied as a 30 mg reference vial with a certificate of analysis. Intended strictly as an analytical reference standard for in vitro receptor and assay research. Store lyophilized material refrigerated and protected from light. Sold for laboratory research use only; not for human or veterinary use, diagnostic, or therapeutic purposes.
Certificate of Analysis
This product is supplied with a third-party lab report (Vanguard Laboratory) for its batch. View the Certificate of Analysis (opens the full certificate in a new tab). For laboratory research use only.
Reviews
There are no reviews yet.